Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Using Serum Biomarkers to Monitor Multiple Sclerosis Disease Activity: Darin T. Okuda, MD, FAAN, FANA
2
FDA Clears Investigational New Drug Application for Remyelinating Agent PTD802 in Multiple Sclerosis
3
NeurologyLive® Friday 5 — June 26, 2026
4
Clinical Impact of FDA's Expanded Efgartigimod Label: Josh Alpers, MD
5